|
|
Title | Creator | Description | Identifier |
1 |
|
What Have We Learned From the Idiopathic Intracranial Hypertension Treatment Trial (Video) | Michael Wall, MD, University of Iowa, Department of Neurology and Ophthalmology | Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH) but there is insufficient information to establish an evidence base for its use.Objective: To determine whether acetazolamide is beneficial in improving vision when added to a low sodium, weight reduction diet in IIH ... | 20150225_nanos_hottopic2_01 |
2 |
|
What Have We Learned From the Idiopathic Intracranial Hypertension Treatment Trial | Michael Wall | Importance: Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH) but there is insufficient information to establish an evidence base for its use. Objective: To determine whether acetazolamide is beneficial in improving vision when added to a low sodium, weight reduction... | 20150225_nanos_hottopic2_01-1 |
3 |
|
What Have We Learned From the Idiopathic Intracranial Hypertension Treatment Trial | Michael Wall, MD, University of Iowa, Department of Neurology and Ophthalmology | Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH) but there is insufficient information to establish an evidence base for its use.Objective: To determine whether acetazolamide is beneficial in improving vision when added to a low sodium, weight reduction diet in IIH ... | 20150225_nanos_hottopic2_01 |